Literature DB >> 11824834

Current status of quality of life assessment in schizophrenic patients.

J Bobes1.   

Abstract

Though the need to evaluate the quality of life of schizophrenic patients is well recognized, there are significant issues that remain unsolved. Are these patients capable of judging their own quality of life or does their illness invalidate their responses? Are there any psychometrically valid instruments that enable us to assess quality of life in these patients? When should quality of life be assessed in schizophrenics? While the ERIQA European Group completes their work and provide us with some common guidelines concerning quality of life assessment in medicine, this article provides some simple action guidelines regarding these questions. These guidelines are the result of analyzing the most up-to-date literature in the field. It also takes a brief look at the most universally used tools.

Entities:  

Mesh:

Year:  2001        PMID: 11824834     DOI: 10.1007/bf03035125

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  15 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Quality of life and mental illness. Reflections from the perspective of the WHOQOL.

Authors:  J Orley; S Saxena; H Herrman
Journal:  Br J Psychiatry       Date:  1998-04       Impact factor: 9.319

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.

Authors:  L Voruganti; R Heslegrave; A G Awad; M V Seeman
Journal:  Psychol Med       Date:  1998-01       Impact factor: 7.723

5.  Using a quality of life measure to investigate outcome in outpatient treatment of severely impaired psychiatric clients.

Authors:  R C Evenson; B W Vieweg
Journal:  Compr Psychiatry       Date:  1998 Mar-Apr       Impact factor: 3.735

6.  A critical appraisal of the quality of quality-of-life measurements.

Authors:  T M Gill; A R Feinstein
Journal:  JAMA       Date:  1994 Aug 24-31       Impact factor: 56.272

7.  Chronic mental patients: the quality of life issue.

Authors:  A F Lehman; N C Ward; L S Linn
Journal:  Am J Psychiatry       Date:  1982-10       Impact factor: 18.112

8.  A new patient focused index for measuring quality of life in persons with severe and persistent mental illness.

Authors:  M Becker; R Diamond; F Sainfort
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

9.  Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives.

Authors:  F Sainfort; M Becker; R Diamond
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Convergent validation of quality of life assessments for persons with severe mental illnesses.

Authors:  A F Lehman; L T Postrado; L T Rachuba
Journal:  Qual Life Res       Date:  1993-10       Impact factor: 4.147

View more
  3 in total

1.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia.

Authors:  Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo
Journal:  Qual Life Res       Date:  2011-02-03       Impact factor: 4.147

Review 3.  Quality of life in schizophrenic patients.

Authors:  Julio Bobes; Maria Paz Garcia-Portilla; Maria Teresa Bascaran; Pilar Alejandra Saiz; Manuel Bousoño
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.